Evidence map›Paper›PMID 33496580›Full record

ArticleJournal of natural products2021

Mitja M Zdouc, Marianna Iorio, Sonia I Maffioli, Max Crüsemann, Stefano Donadio, Margherita Sosio

Open access · hybridAbstract read
In one paragraph

Article in Journal of natural products, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Microbial Metabolites Annotation by Mass Spectrometry-Based Metabolomics.Advances in experimental medicine and biology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Effective approaches to discover new microbial metabolites in a large strain library.Journal of industrial microbiology & biotechnology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Mitja M ZdoucNaicons Srl., Viale Ortles 22/4, 20139 Milano, Italy.ORCID 0000-0001-6534-6609
Marianna IorioNaicons Srl., Viale Ortles 22/4, 20139 Milano, Italy.ORCID 0000-0001-8669-5875
Sonia I MaffioliNaicons Srl., Viale Ortles 22/4, 20139 Milano, Italy.ORCID 0000-0001-5489-5995
Max CrüsemannInstitut für Pharmazeutische Biologie, Rheinische Friedrich-Wilhelms-Universität, Nußallee 6, 53115 Bonn, Germany.ORCID 0000-0001-6660-2715
Stefano DonadioNaicons Srl., Viale Ortles 22/4, 20139 Milano, Italy.
Margherita SosioNaicons Srl., Viale Ortles 22/4, 20139 Milano, Italy.
University of Amsterdam · NLUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite an excellent track record, microbial drug discovery suffers from high rates of rediscovery. Better workflows for the rapid investigation of complex extracts are needed to increase throughput and to allow early prioritization of samples. In addition, systematic characterization of poorly explored strains is seldomly performed. Here, we report a metabolomic study of 72 isolates belonging to the rare actinomycete genus

Indexed as

MetabolomicsActinobacteriaChromatography, LiquidGenome, BacterialMultigene FamilyPhylogenySiderophoresTandem Mass SpectrometrySiderophores

Identifiers

PMID33496580
PMCPMC7922807
OpenAlexW3123030036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.